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Purpose: The aim of the present study was first to validate a near infrared (NIR) 
method for the active content determination of non-coated pharmaceutical pellets. The 
second aim was to select the prediction model which was the most fitted for purpose. 
Further, the reliability of the selected model was tested. 
Method: To meet the requirements of routine analysis, variability sources such as 
batches, operators, days and different temperature conditions were included in the 
calibration and validation set. PLS regression on the calibration set was carried out for the 
development of prediction models of which ability to quantify accurately was tested 
with the validation set. 
Results: A preliminary selection of 3 models was accomplished by checking the R2, the 
Root Mean Square Error of Calibration and Prediction (RMSEC and RMSEP). 
However, none of those commonly used criteria were able to distinguish the most fitted 
model for purpose among the 3 selected ones. Accordingly, a novel approach based on 
tolerance interval and total error measurements was followed: accuracy profiles based 
on the validation results. Following that approach, the prediction model using signal pre-
treatment Multiplicative Scatter Correction (MSC) was chosen as it showed the best ability 
to quantify accurately the active content over the chosen active range (80-120 % of the 
targeted content).The reliability of the selected model was then successfully tested with 
new pilot batches of non-coated pharmaceutical pellets containing 90 and 110 % of the 
labeled active content, with blends of validation batches and Industrial batches.  
Conclusion: In the face of the limit of interpretation of the classical and common-used 
criteria, the use of the accuracy profile based on the validation results as a decision tool has 
allowed to choose the best model in full accordance with the very final goal of the NIR 
method: to quantify accurately the active content (acceptance limits: ± 5%). The adequacy 
of the NIR method and its interchangeability with its HPLC reference method was 
confirmed by mean of Industrial batches. 
